Joel Isaacson & Co. LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Joel Isaacson & Co. LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,468 shares of the healthcare conglomerate’s stock after buying an additional 662 shares during the quarter. Joel Isaacson & Co. LLC’s holdings in UnitedHealth Group were worth $3,272,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of UNH. Arcataur Capital Management LLC grew its holdings in UnitedHealth Group by 14.1% during the 4th quarter. Arcataur Capital Management LLC now owns 1,252 shares of the healthcare conglomerate’s stock valued at $633,000 after purchasing an additional 155 shares during the last quarter. Generate Investment Management Ltd lifted its stake in shares of UnitedHealth Group by 54.0% during the 4th quarter. Generate Investment Management Ltd now owns 67,628 shares of the healthcare conglomerate’s stock worth $34,210,000 after acquiring an additional 23,710 shares during the last quarter. Harvey Investment Co. LLC increased its stake in UnitedHealth Group by 4.1% in the fourth quarter. Harvey Investment Co. LLC now owns 4,841 shares of the healthcare conglomerate’s stock worth $2,449,000 after purchasing an additional 190 shares during the period. Lecap Asset Management Ltd. grew its holdings in shares of UnitedHealth Group by 457.2% in the fourth quarter. Lecap Asset Management Ltd. now owns 5,633 shares of the healthcare conglomerate’s stock worth $2,850,000 after purchasing an additional 4,622 shares during the last quarter. Finally, Golden State Wealth Management LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $867,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on UNH. TD Cowen boosted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Down 0.6 %

NYSE UNH opened at $526.68 on Friday. The company has a fifty day moving average of $530.85 and a 200 day moving average of $564.52. The company has a market capitalization of $484.69 billion, a PE ratio of 33.98, a P/E/G ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the business earned $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.